Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RIC8 guanine nucleotide exchange factor B (RIC8B) is a cytosolic protein acting as a chaperone and a guanine nucleotide exchange factor (GEF) for certain G protein alpha subunits, particularly Gαs and Gαolf[2][3]. It catalyzes the exchange of GDP for GTP on these Gα subunits prior to their assembly into heterotrimeric G proteins and supports their proper folding, cellular stability, and association with the plasma membrane[2][3]. RIC8B is essential in the regulation of G protein-coupled receptor (GPCR) signaling cascades, especially in odorant signal transduction within olfactory sensory neurons, where it mediates Gαolf folding and subsequent cAMP accumulation[2][3]. RIC8B is structurally characterized by armadillo (ARM) and HEAT α-helical repeats forming a concave binding pocket that confers its specificity and chaperone activity for Gαs/olf-type proteins[2]. Dysfunction or mutation of RIC8B is associated with disorders including neurodevelopmental and neurodegenerative phenotypes[3]. No clinically approved drugs are reported to directly target RIC8B, and it is not established as a biomarker or a drug safety concern based on currently available data.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RIC8 guanine nucleotide exchange factor B (RIC8B).